Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
Shuxin Yan, Jintong Na, Xiyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 248-248
Open Access | Times Cited: 42
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 20
A Review: Surface Engineering of Lipid‐Based Drug Delivery Systems
Dhaval Patel, Jyoti Solanki, Mafatlal M. Kher, et al.
Small (2024) Vol. 20, Iss. 43
Open Access | Times Cited: 20
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
Alessandra Spada, Sandrine Gerber‐Lemaire
Nanomaterials (2025) Vol. 15, Iss. 3, pp. 158-158
Open Access | Times Cited: 3
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 15
Single-atom nanozymes: From bench to bedside
Chanyuan Jin, Sanjun Fan, Zechao Zhuang, et al.
Nano Research (2022) Vol. 16, Iss. 2, pp. 1992-2002
Open Access | Times Cited: 35
Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects
Yanxiang Cheng, Zhen Qu, Jiang Qian, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 21
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2661-2661
Open Access | Times Cited: 18
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors
Anastasia N. Shishparenok, Vitalina V. Furman, Dmitry D. Zhdanov
Cancers (2023) Vol. 15, Iss. 7, pp. 2151-2151
Open Access | Times Cited: 17
Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer
Monserrat Llaguno‐Munive, Maria Inés Vazquez-Lopez, Patricia García‐López
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10712-10712
Open Access | Times Cited: 7
Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
Zongyi Wei, Yuxin Zhou, Rongjie Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2561-2561
Open Access | Times Cited: 27
Aptamers: Features, Synthesis and Applications
Aiswarya P. U, Gopika Raj, Jinju John, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 10
Closed Access | Times Cited: 13
Nanomedicine Strategies for Targeting Tumor Stroma
Mei‐Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4145-4145
Open Access | Times Cited: 10
Harnessing the Human Microbiome and its Impact on Immuno-Oncology and Nanotechnology for Next-Generation Cancer Therapies
Mamali Das, Chandramohan Kiruthiga, Rajamohamed Beema Shafreen, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177436-177436
Closed Access
CD44 and Its Role in Solid Cancers – A Review: From Tumor Progression to Prognosis and Targeted Therapy
João Martins Gama, Rui Caetano Oliveira
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment
Reza Ghavimi, Samira Mahmoudi, Mohsen Mohammadi, et al.
Research in Pharmaceutical Sciences (2025) Vol. 20, Iss. 2, pp. 165-187
Open Access
Advances in the use of nanoparticles for specific cell-target delivery of anti-cancer agents
Ana Belén Diaz-Ruano, Eliana Gomez-Jimenez, Gloria Llamas-Jimenez, et al.
Life Sciences (2025) Vol. 371, pp. 123604-123604
Closed Access
Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance
Syed Mubashar Sabir, Ali Salman B. Thani, Qamar Abbas
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Phenyl boronic acid conjugated lipid nanoparticles for targeted delivery of gamma-secretase inhibitor to breast cancer cells
G. Ramakrishna, N Prasanthi, Sai Kiran S. S. Pindiprolu
Drug Development and Industrial Pharmacy (2025), pp. 1-19
Closed Access
Solid Lipid Nanoparticles Based on Babassu Oil and Copaiba Oleoresin: A Promising Approach for Prostate Cancer Therapy
Michael Jackson Ferreira da Silva, Alisson Mendes Rodrigues, Maria Célia Pires Costa, et al.
Nanomaterials (2024) Vol. 14, Iss. 12, pp. 1014-1014
Open Access | Times Cited: 3
Development, Statistical Optimization, and Characterization of Resveratrol‐Containing Solid Lipid Nanoparticles (SLNs) and Determination of the Efficacy in Reducing Neurodegenerative Symptoms Related to Alzheimer’s Disease: In Vitro and In Vivo Study
Mohammad Amin Khishvand, Ehsan Mehrabani Yeganeh, Mohammad Zarei, et al.
BioMed Research International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
ANTICANCER LIPID-BASED DRUG DELIVERY SYSTEMS: BASIC KNOWLEDGE AND RECENT APPLICATIONS
Mohamed M. Shehata
Nano TransMed (2024), pp. 100054-100054
Open Access | Times Cited: 3
αvβ3 integrin aptamer functionalized pH-responsive lipid polymer hybrid nanoparticles for targeted co-delivery of paclitaxel and tamoxifen
Mahavir Narwade, Niladri Haldar, Rajkumar Samanta, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141754-141754
Closed Access
Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies
Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2648-2648
Open Access | Times Cited: 6
Modulation of the Tumor Stroma and Associated Novel Nanoparticle Strategies to Enhance Tumor Targeting
H. Haze, Cornelis F.M. Sier, Alexander L. Vahrmeijer, et al.
Surgeries (2024) Vol. 5, Iss. 1, pp. 49-62
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top